drugset / Trial / NCT00534807

A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

NCT00534807

Phase 1 Withdrawn Bristol-Myers Squibb
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test how vinflunine interacts with rifampin in the human body

Timeline

Start
2007-09
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifampin Small molecule
Subject Vinflunine Small molecule

Indications